Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Simon Latimer - Head, Investor Relations Todd Davis - Chief Executive Officer Tavo Espinoza - Chief Financial Officer Matt Korenberg - President and Chief Operating Officer Conference Call Participants Joe Pantginis - H.C. Wainwright Matt Hewitt - Craig-Hallum Capital Group Larry Solow - CJS Securities Operator Thank you for standing by. My name is Brian, and I will be your confe ...